Synopsis:- In a departure from current apply, MPS Restricted’s board has declined to suggest a last dividend for FY26, citing capital deployed towards the USD 16.5 million acquisition of Unbound Medication, Inc., at the same time as the corporate reported consolidated web revenue of Rs. 173 crore for the 12 months ended March 31, 2026 up 16 p.c year-on-year and cleared a full governance slate overlaying auditor appointments and a pending merger scheme.
A B2B studying and content material options firm used its Might 15, 2026 board assembly to ship FY26 outcomes, a dividend choice that broke from current precedent, and a governance overhaul spanning each inner and statutory audit appointments. The board accredited the audited standalone and consolidated monetary outcomes for This autumn and the complete 12 months ended March 31, 2026, with an unmodified opinion from Walker Chandiok & Co LLP after which selected to retain capital slightly than pay out a last dividend for the primary time in current reminiscence.
With a market capitalization of roughly Rs. 3,109.84 crore, the shares of MPS Ltd final traded at Rs. 1,818 per share, up 11.27 p.c from its earlier shut of Rs.1,633.9. It’s buying and selling at a P/E of 16.13.
On a consolidated foundation, MPS reported income from operations of Rs. 768 crore for FY26, up 5.7 p.c year-on-year from Rs. 727 crore in FY25. Web revenue for the 12 months got here in at Rs. 173 crore a 16.3 p.c enhance over the prior 12 months’s Rs. 149 crore with consolidated primary EPS at Rs. 102.11 in opposition to Rs. 87.80 in FY25. ROCE stands at 40.9 p.c and ROE at 30.5 p.c, each among the many stronger figures within the content-tech companies house.
The standalone numbers inform a sharper development story. Standalone income grew 24.8 p.c year-on-year to Rs. 438 crore in FY26, with standalone PAT at Rs. 127 crore, up from Rs. 110 crore. The hole between the consolidated and standalone development charges displays the truth that subsidiaries, significantly the Liberate Group, consolidated from late October 2025 dragged the consolidated headline whereas the India-based core operations accelerated.
The consolidated phase information is the place the FY26 story will get granular. Analysis options, the group’s largest enterprise, generated income of Rs. 464 crore for the complete 12 months, barely transferring from Rs. 459 crore in FY25 a 1 p.c achieve that displays each the maturity of the publishing content material companies market and the bottom impact of a powerful prior 12 months. Section revenue, nonetheless, grew 11.1 p.c to Rs. 170 crore from Rs. 153 crore, which means Analysis is extracting extra working leverage from a near-flat income line. That could be a optimistic sign on margin administration.
Schooling options was the expansion engine of the 12 months. Income rose 36.3 p.c to Rs. 209 crore from Rs. 153 crore in FY25, and phase revenue expanded 40.9 p.c to Rs. 77 crore from Rs. 55 crore. The margin growth right here phase revenue as a share of income improved barely suggests the expansion was not purchased via pricing concessions. This phase is now giant sufficient to meaningfully offset weak point elsewhere within the group.
Company studying is the issue phase. Income fell 16.5 p.c to Rs. 96 crore from Rs. 115 crore in FY25, and phase revenue collapsed 43.5 p.c to Rs. 11 crore from Rs. 20 crore. The Liberate Group, acquired by MPS Interactive Methods Restricted in October 2025, sits inside this phase, and the This autumn goodwill impairment of Rs. 12.93 crore was particularly tied to a reassessment of Liberate’s carrying worth following its integration into the unified Liberate World model in April 2026.
In different phrases, the phase is absorbing each integration prices and a write-down inside the similar reporting interval which makes the diploma of underlying deterioration more durable to isolate. The following two quarters will decide whether or not company studying stabilises or continues to compress the consolidated margin profile.
On a standalone foundation, the two-segment image is cleaner. Analysis options grew 20.6 p.c to Rs. 305 crore, with phase revenue up 16.7 p.c to Rs. 135 crore. Schooling options expanded 35.4 p.c to Rs. 133 crore, with phase revenue up 36.7 p.c to Rs. 73 crore. The standalone enterprise is firing on each segments with out the drag of the company studying integration which additionally explains why standalone income development at 24.8 p.c outpaced the consolidated determine of 5.7 p.c so considerably.
MPS paid a last dividend of Rs. 50 per share in FY25, a payout of roughly Rs. 86 crore on the present share rely. The board’s FY26 choice to withhold that payout is framed squarely round capital utilization: the Unbound Medication, Inc. acquisition, accomplished on February 9, 2026, consumed money and required exterior borrowings of Rs. 42 crore on prime of inner accruals, for a complete deal consideration of USD 16.5 million.
The capital allocation framework cited within the submitting is price noting capital is returned to shareholders solely when deployment alternatives on the firm’s return thresholds are unavailable inside a twelve-month horizon. That language alerts administration views its post-acquisition integration pipeline as a deployment alternative, not a holding sample.
Unbound Medication brings a medical medical reference platform into the MPS group, a content material kind that sits adjoining to the analysis options enterprise and will feed cross-sell alternatives within the healthcare publishing vertical. The provisional goodwill acknowledged at acquisition stands at Rs. 123.86 crore, topic to working capital adjustment, which implies a last buy worth allocation will seem in subsequent filings.
Governance: KPMG In, Walker Chandiok Staying, NCLT Watch
The board accredited KPMG Assurance and Consulting Providers LLP as inner auditors for 3 consecutive monetary years beginning FY27, overlaying each MPS Restricted and its materials subsidiary MPS Interactive Methods Restricted. The appointment extends KPMG’s mandate uniformly throughout the group, changing what was presumably a extra fragmented audit oversight construction.
Walker Chandiok & Co LLP, the statutory auditor, obtained a second five-year time period working from the conclusion of the upcoming 56th AGM via the 61st AGM in 2031, topic to shareholder approval. The auditor’s current-year report carries an unmodified opinion.
On the company restructuring entrance, the proposed merger of ADI BPO Providers Restricted into MPS Restricted accredited by the board on July 18, 2025 and cleared by the inventory trade in March 2026 was filed earlier than the NCLT Chennai Bench on April 17, 2026, and stays pending a listening to date. If accredited, the merger will fold ADI BPO’s residual post-demerger entity into MPS, tidying up the group construction that emerged after ADI BPO’s infrastructure and investing companies had been separated.
Enterprise Overview
MPS Restricted, included in 1970 and listed on each the BSE (532440) and NSE (MPSLTD), is a B2B content material and studying options firm serving schooling and analysis purchasers globally. The corporate operates throughout three segments: analysis options, schooling options, and company studying via a subsidiary community spanning the USA, Europe, Australia, and Germany.
Disclaimer: The views and funding suggestions expressed by funding consultants/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Buyers should subsequently train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Non-public Restricted or the writer aren’t accountable for any losses precipitated on account of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
